LifeStance Health Group (NASDAQ:LFST – Get Free Report) is expected to be posting its quarterly earnings results before the market opens on Thursday, February 27th. Analysts expect LifeStance Health Group to post earnings of ($0.04) per share and revenue of $313.96 million for the quarter. Individual that wish to listen to the company’s earnings conference call can do so using this link.
LifeStance Health Group Stock Performance
NASDAQ:LFST opened at $7.52 on Wednesday. The stock’s fifty day moving average is $7.77 and its 200 day moving average is $7.20. LifeStance Health Group has a fifty-two week low of $4.64 and a fifty-two week high of $9.20. The firm has a market capitalization of $2.88 billion, a PE ratio of -28.90 and a beta of 1.28. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.32 and a current ratio of 1.32.
Wall Street Analysts Forecast Growth
Several analysts recently weighed in on the company. The Goldman Sachs Group upgraded LifeStance Health Group from a “neutral” rating to a “buy” rating and set a $10.00 price target on the stock in a report on Monday, December 16th. Barclays increased their target price on LifeStance Health Group from $6.00 to $7.00 and gave the stock an “underweight” rating in a research note on Monday, November 11th. One research analyst has rated the stock with a sell rating, one has given a hold rating and three have issued a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $8.70.
LifeStance Health Group Company Profile
LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.
Read More
- Five stocks we like better than LifeStance Health Group
- How to Use Stock Screeners to Find Stocks
- Nebius Slides Post-Earnings: A Long-Term Buy Opportunity?
- Energy and Oil Stocks Explained
- NVIDIA Stock: A Market Barometer in Tech’s Turbulent Times
- How to Calculate Options Profits
- Palantir Stock Nears Bear Market Territory – Why and What’s Next?
Receive News & Ratings for LifeStance Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeStance Health Group and related companies with MarketBeat.com's FREE daily email newsletter.